Off-label male use

The male erectile-dysfunction story: real early data, no modern Phase 3

PT-141 is widely discussed for male use, yet the drug is not approved in men. This unit reads that off-label story honestly: there is genuine early controlled evidence from the intranasal and early subcutaneous era, and there is a clear gap where a modern trial should be.

It walks the original male studies, the sildenafil-combination result, the reason the program was halted, and why extrapolating from the female HSDD approval to male use is reasonable mechanism but not proven outcome.